DBV Technologies Anticipates Peanut Patch BLA Filing in Q3 2026
DBV Technologies anticipates filing its Biologics License Application for the VIASKIN Peanut Patch in children aged 4 through 7 years in Q3 2026. The company received guidance to reformat data without needing to conduct additional clinical trials.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day